Back to Ensign Peak Advisors, Inc Ensign Peak Advisors, Inc

TNGXTNGX
15 quarters

Position history for Ensign Peak Advisors, IncEnsign Peak Advisors, Inc's holdings in Tango Therapeutics, Inc.

Ensign Peak Advisors, Inc previously held 0 shares of TNGX (Tango Therapeutics, Inc.), worth $0 as of 2025-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$692,000

Total Shares Change

-53,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$1.47
0
2024-Q4
Increased
57,319
+100.3%
$177,1160.0%$3.10
37
2024-Q3
Decreased
28,619
-89.5%
$220,3660.0%$7.47
0
2024-Q2
Decreased
271,822
-46.3%
$2.3M0.0%$8.58
0
2024-Q1
Increased
506,382
+2.3%
$4M0.0%$7.94
27
2023-Q4
Unchanged
495,213
0.0%
$4.9M0.0%$9.90
0
2023-Q3
Unchanged
495,213
0.0%
$5.6M0.0%$11.26
0
2023-Q2
Unchanged
495,213
0.0%
$1.6M0.0%$3.26
0
2023-Q1
Unchanged
495,213
0.0%
$2M0.0%$3.92
0
2022-Q4
Increased
495,213
+27.6%
$3.6M0.0%$7.25
33
2022-Q3
Increased
387,953
+29.6%
$1.4M0.0%$3.60
32
2022-Q2
Increased
299,391
+183.4%
$1.4M0.0%$4.32
41
2022-Q1
Unchanged
105,656
0.0%
$801,0000.0%$7.75
0
2021-Q4
Increased
105,656
+97.5%
$1.2M0.0%$10.86
40
2021-Q3
New
53,500
-
$692,0000.0%$12.03
34

Other major holders of TNGX: RTW INVESTMENTS, LP, BlackRock, Inc., FMR LLC, FARALLON CAPITAL MANAGEMENT, L.L.C., GOLDMAN SACHS GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used